Growth funding Hexarad secured significant growth funding of €13M in 2024, signaling financial backing and expansion potential. This indicates capacity to invest in platform enhancements, additional radiology capacity, and scaling partnerships with NHS trusts and private hospitals.

Award driven Recipient of HSJ awards for Diagnostics Project of the Year and partnerships that reduced diagnostic waiting times, highlighting a proven track record in improving efficiency. This can be leveraged to position Hexarad as a trusted efficiency partner for health systems seeking to accelerate radiology turnaround times.

End-to-end platform Offers a comprehensive radiology solution including ReportRad teleradiology and OptiRad department optimization tools. This dual capability aligns with hospitals seeking to outsource imaging workload while retaining operational oversight and quality control.

Public sector traction Notable collaboration with North West Anglia NHS Foundation Trust and documented A&E referral time savings. Opportunity to expand within NHS trusts and acute care settings that require rapid diagnostic workflows and reduced patient wait times.

Innovation momentum History of expanding capabilities such as automated scan routing and registrar health technology fellowships indicates ongoing product development and talent pipelines. Use this to engage health tech buyers looking for forward-looking radiology platforms and skilled radiology support.